Logo Image
News|Articles|December 2, 2016

PTSM: Pharmaceutical Technology Sourcing and Management

  • PTSM: Pharmaceutical Technology Sourcing and Management-12-07-2016
  • Volume 11
  • Issue 12

Recipharm Collaborates with Laccure AB

Recipharm and Laccure AB signed a commercial collaboration for the manufacture and delivery of Laccure’s bacterial vaginosis treatment.

On Dec. 1, 2016 Recipharm announced that it has entered a commercial collaboration with Laccure AB for the manufacture and delivery of Laccure Pessary, a non-prescription vaginal tablet for the treatment of bacterial vaginosis. Laccure Pessary will be manufactured, packaged, and distributed globally from Recipharm’s facility in Karlskoga that specializes in the production of semi-solid products. Recipharm and Laccure AB have now signed an agreement for commercial production of Laccure Pessary, and the exact date for the launch will be announced in 2017. Laccure Pessary is based on a patented substance that releases lactic acid.

Source: Recipharm

 

Articles in this issue

over 9 years ago

Factors to Consider in Dissolution Testing

over 9 years ago

Internal and External Factors to Shape CMO Industry

over 9 years ago

New Opportunities for Cocrystals

over 9 years ago

Analytical Method Validation Using QbD and QRM

over 9 years ago

Vetter Processing Center Receives Data Certification

over 9 years ago

Idifarma Invests in Automatic Capsule Filling Capabilities

over 9 years ago

Catalent Expands Softgel Capacity with Accucaps Acquisition

over 9 years ago

Patheon Acquires Roche API Site

over 9 years ago

FDA Guidance Helps Further Clarify Quality Agreements

over 9 years ago

PCI Expands Cryogenic Storage Facilities to Rockford Site

Related Content